Impaired NET clearance in SLE, attributed to anti-DNase I antibodies (53), allows persistent High Mobility Group Box 1 (HMGB1) release that exacerbates chemotaxis and cytokine storms (4, 54). The gene discussed is HMGB1; the disease is systemic lupus erythematosus.